Cargando…
Factors Driving COVID-19 Vaccine Hesitancy in Cameroon and Their Implications for Africa: A Comparison of Two Cross-Sectional Studies Conducted 19 Months Apart in 2020 and 2022
Many efficacious COVID-19 vaccines have been approved for general use but their ability to control the disease is being undermined by slow uptake. Resources are needed to persuade people to obtain a COVID-19 vaccine. Here we compare this present study and a previous one to assess the impact of the C...
Autores principales: | Dinga, Jerome Nyhalah, Njoh, Andreas Ateke, Gamua, Stanley Dobgima, Muki, Synthia Eni, Titanji, Vincent P. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503216/ https://www.ncbi.nlm.nih.gov/pubmed/36146479 http://dx.doi.org/10.3390/vaccines10091401 |
Ejemplares similares
-
Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2021) -
Analysis of the Role of TpUB05 Antigen from Theileria parva in Immune Responses to Malaria in Humans Compared to Its Homologue in Plasmodium falciparum the UB05 Antigen
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2020) -
Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05‐09 is associated with protective immunity against malaria
por: Dinga, J. N., et al.
Publicado: (2017) -
Fetal malformation in maternal toxoplasma and rubella co-infection in Cameroon: a case report
por: Njoh, Andreas Ateke, et al.
Publicado: (2016) -
Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum
UB05‐09 antigen could be a malaria vaccine candidate
por: Dinga, J. N., et al.
Publicado: (2018)